Russia

Capital	Moscow
Area	17,075,400 km2
Population	142,400,000
Urbanization rate	73%
GCT presence	Russian head office in Saint Petersburg, office in Moscow

World’s largest country with urbanized dense population centers such as Europe’s largest metropolitan area of Moscow (15 millions), Saint-Petersburg (6 millions), Novosibirsk and Nizhniy Novgorod (2,5 millions), and a dozen more millionaire cities; centralized medical system and academic centers for all therapeutic areas, western medical techniques and highly-qualified investigators — that’s what makes Russia a place of choice when you need to enroll.

Russia continues to remain one of the fastest growing clinical research areas of the world, and for all the right reasons. When you consider the major population centers combined with the larger medical institutions, patient access and medical need it is hard to find a better location for clinical research.

Here are some of the key reasons why Russia continues to be rated so high by research organizations from around the world.

• Rapid study initiation (typically 10-15 weeks from documents submission to first patient enrolled);
• Low relocation rate;
• Academic centers and specialized hospitals for all therapeutic areas;
• Opinion leaders in each therapeutic area;
• Western medical techniques/processes;
• MD's — six years in medical school and follow-up certification every five years

© Global Clinical Trials, LLC
privacy statement, website info